What's the role of topiramate in the management of patients with hyperkinetic movement disorders? (Q38009653)

26 August 2017

title

What's the role of topiramate in the management of patients with hyperkinetic movement disorders? (English)

1 reference

26 August 2017

3

Chiara Giofrè

0 references

Giovambattista De Sarro

4

object named as

Giovambattista De Sarro

0 references

author name string

Antonio Siniscalchi

1

1 reference

26 August 2017

Luca Gallelli

2

1 reference

26 August 2017

Chiara Giofrè

3

1 reference

26 August 2017

Giovambattista De Sarro

4

1 reference

26 August 2017

publication date

1 January 2012

1 reference

26 August 2017

published in

Pharmacological Reports

1 reference

26 August 2017

volume

64

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

24-30

1 reference

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Restless legs syndrome induced by topiramate: two more cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Is the anticonvulsant topiramate beneficial in essential tremor?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Chorea and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

A double-blind placebo-controlled trial of topiramate treatment for essential tremor

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Functional anatomy of movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Hemichorea-hemiballismus may respond to topiramate

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Restless legs syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

GABAergic circuits in the basal ganglia and movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Vascular hemichorea/hemiballism and topiramate

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate therapy for paroxysmal kinesigenic choreoathetosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Treatment of hyperkinetic movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Dystonia and chorea in acquired systemic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

How are we doing with the treatment of essential tremor (ET)?: Persistence of patients with ET on medication: data from 528 patients in three settings

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Pharmacotherapy of essential tremor : an overview of existing and upcoming agents

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

[Pathophysiology of restless legs syndrome]

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Psychopharmacology of topiramate: from epilepsy to bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate in essential tremor: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate: a new antiepileptic drug

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Synaptic control of motoneuronal excitability.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Action tremor with alternating activity in antagonist muscles

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Restless legs syndrome: an update on treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Safety of topiramate: adverse events and relationships to dosing

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Efficacy and tolerability of topiramate in vascular generalized chorea

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Combined topiramate and declorazepam therapy in a patient affected by essential tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Drugs treatment of pain in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Review of topiramate for the treatment of epilepsy in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970727-2

7 January 2021

10.1016/S1734-1140(12)70727-2

Identifiers

DOI

1 reference

26 August 2017

1 reference